Sun Pharmaceutical Industries informs about updates

18 Dec 2025 Evaluate

Sun Pharmaceutical Industries has informed that the US FDA conducted an inspection at the Company’s Baska facility from 8 September 2025 to 19 September 2025. The US FDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI). The company continue to manufacture and supply approved products from the facility to the US market. The company will work with the regulator to achieve fully compliant status.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma Inds. Share Price

1745.35 -49.75 (-2.77%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×